Dobutamine In Dextrose
Injection
Current Active — Day 3111
FDA shortage record
- Substance
- Dobutamine In Dextrose
- Manufacturers / suppliers
-
- Hospira, Inc.
- Hospira, Inc., a Pfizer Company
- Dosage form
- Injection
- Presentation
- Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 1,000 mg/250mL (400 mg/mL) (NDC 0409-3724-32)
- Route(s)
- INTRAVENOUS
- Therapeutic category
- Cardiovascular, Pediatric, Renal
- Package NDC
0409-3724-32- Initially posted
- 11/06/2017
- Days on shortage list
- 3111
- Current FDA status
- Current
- Shortage entries (current dataset)
- 1 record for Dobutamine In Dextrose
Why this shortage matters
Cardiovascular drugs manage heart failure, arrhythmias, hypertension, and coronary artery disease. Shortages can disrupt stable long-term therapy or create gaps in acute care where dosing consistency is essential to preventing cardiac events.
FDA therapeutic class: Cardiovascular, Pediatric, Renal
Reason and context
Reason reported: Other
Next Delivery: May 2026; Estimated Recovery: June 2026; Shortage per Manufacturer: Manufacturing Delay
Manufacturer contact
Per the FDA record, the manufacturer's contact for supply inquiries is 844-646-4398.
If you're affected by this shortage
- Talk to your prescribing clinician or pharmacist about therapeutic alternatives. Do not switch medications on your own.
- Ask your pharmacy to check supply across multiple wholesalers and other branches.
- Check current pharmacy pricing and availability via GoodRx (affiliate link).
- Report a continuing supply problem to FDA via the FDA Drug Shortages contact form.
Sources
- FDA Drug Shortages database, accessed via the openFDA Drug Shortages API.
- FDA Structured Product Label (SPL set ID
9943a961-3b50-4847-8a84-d8414ce38daa). - FDA UNII identifier:
0WR771DJXV. - See the Drug Shortage Tracker methodology for sourcing, update cadence, normalization rules, and limits.
Important
This page reproduces publicly available FDA shortage data for informational purposes only. It is not medical advice and does not establish a clinician-patient relationship. Shortage status changes frequently; verify directly with your pharmacist or the FDA Drug Shortages site before making any treatment decision.